We believe that reality is exactly what we perceive but really, this is just an illusion of our own brain. This happens because our brain takes shortcuts to interpret information and adapt to our surroundings: heuristics on which the brain relies to understand the reality perceived, but… can we always trust our brain when it utilizes these resources?
This week, I had the pleasure of speaking with Dr. Keith Frankish, a European philosopher and writer. I was first introduced to Dr. Frankish’s theory by David Chalmers’ keynote speech at The Science of Consciousness. The theory is Illusionism. Do we have consciousness or does it SEEM as if we have consciousness? Dr. Frankish is an Honorary Reader at the University of Sheffield, a Visiting Research Fellow with The Open University, and an Adjunct Professor with the Brain and Mind Programme at the University of Crete. His focus is primarily in philosophy of mind, but he has interests in many areas of philosophy. Please enjoy this conversation on Illusionism with Dr. Keith Frankish. http://theconsciousnesspodcast.com/
It’s true that dogs demand a lot from their owners—but they also offer a lot in return.
Are you on the fence about getting a dog? Worried that he’ll pee on the carpet or chew the furniture? Well, he might—at least at first. But he’ll also add so much joy and love to your life. And the benefits of having a dog don’t stop at him being adorable and snuggly; according to a growing body of science, dogs can be good for your physical and mental health, too. Here’s what the research has to say:
Novartis is offering a $250,000 prize to fund development of pioneering innovation with great potential in advancing Assistive Tech for Multiple Sclerosis. Applications will be accepted until January 10, 2020, and the winners will be announced during a panel discussion among experts in the field at SXSW in Austin, TX.
This study involved 4,717 participants from two different community-based cohorts. A meta-analysis of both cohorts showed that elevated sCD14 was associated with a 12 percent increased risk of dementia as people got older. Higher levels of sCD14 were also associated with accelerated brain aging in both cohorts, a faster progression of age-related brain atrophy, and a more rapid decline of executive functions.
The authors sum up their findings: “sCD14 is an inflammatory marker related to brain atrophy, cognitive decline, and incident dementia.”
“Higher levels of sCD14 were associated with markers of brain aging and injury, such as total brain atrophy and a decline in executive functioning—the decision-making needed for many activities of daily life,” first author Matthew Pase, of the Florey Institute for Neuroscience and Mental Health in Melbourne, Australia, said in a news release.
